![Tiago Girão](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 10 M $ al 31/08/2026
Tiago M.
Girão is currently Chief Financial Officer at Proteovant Therapeutics, Inc. and will be Chief Financial Officer at Immunovant, Inc. starting in 2025.
Former positions include Independent Director at Landos Biopharma, Inc. from 2021 to 2024; International Controller at NuVasive LLC from 2012 to 2014; Senior Manager at KPMG LLP from 2000 to 2004; Chief Financial Officer & Vice President at Plus Therapeutics, Inc. from 2014 to 2015; Senior Accountant at Ernst & Young Terco; Chief Financial Officer at Roivant Sciences, Inc.; and Chief Financial Officer & Senior VP-Operations at Cytori Therapeutics, Inc. from 2014 to 2019.
Education includes an undergraduate degree from the University of Fortaleza.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
IMMUNOVANT INC 0,12 % | 23/07/2026 | 240.798 ( 0,12 % ) | 10 M $ | 31/08/2026 |
| 25/07/2018 | 1 ( -.--% ) | 3 $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| IMMUNOVANT, INC. | Director Financiero/CFO | 18/04/2025 |
Proteovant Therapeutics, Inc. | Director Financiero/CFO | - |
| Empresas | Cargo | Fin |
|---|---|---|
| LANDOS BIOPHARMA, INC. | Director/Miembro de la Junta | 23/05/2024 |
| CERENOME, INC. | Director Financiero/CFO | 31/03/2019 |
Cytori Therapeutics, Inc.
 Cytori Therapeutics, Inc. BiotechnologyHealth Technology Engages in development of treatment and devices for cell therapy | Director Financiero/CFO | 01/03/2019 |
| NUVASIVE, INC. | Comptroller/Controller/Auditor | 01/08/2014 |
KPMG LLP
 KPMG LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, tax and advisory services | Corporate Officer/Principal | 01/08/2004 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 10 |
|---|---|
NuVasive, Inc.
 NuVasive, Inc. Medical SpecialtiesHealth Technology Designs and develops medical devices for the surgical treatment of spine disorders | Health Technology |
KPMG LLP
KPMG LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, tax and advisory services | Commercial Services |
Plus Therapeutics, Inc.
 Plus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops radio therapeutics products | Health Technology |
Ernst & Young Terco
 Ernst & Young Terco Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
University of Fortaleza
 University of Fortaleza Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Landos Biopharma, Inc.
 Landos Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company focused on the discovery and development of oral therapeutics for patients with autoimmune diseases | Health Technology |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Health Technology |
Immunovant, Inc.
 Immunovant, Inc. BiotechnologyHealth Technology Develops restorative therapies for autoimmune diseases | Health Technology |
Cytori Therapeutics, Inc.
Cytori Therapeutics, Inc. BiotechnologyHealth Technology Engages in development of treatment and devices for cell therapy | Health Technology |
Proteovant Therapeutics, Inc. |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
